New Heart Device for High Risk Patients

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.
In November, a heart valve replacement device received FDA approval that cardiologists and cardiac surgeons say could be a huge breakthrough in how they repair calcified heart valves in high risk patients. The buzz surrounding the transcatheter aortic valve replacement (TAVR) allows doctors to replace a heart valve by inserting it through a catheter into the heart.